Which of these companies helping to fight the pandemic is the better buy for investors?
News & Analysis: Pfizer
Investors are excited about the drug maker's experimental coronavirus vaccine.
Patients developed antibodies to the coronavirus in the phase 1 clinical trial, but the vaccine also produced side effects.
It's certainly tempting. But there are reasons to hold off.
While the data looks good so far, the duo's treatment is behind a similar BioMarin therapy in the testing and approval process.
Only one of these two pharma titans has a history of growth.
Bristol Myers Squibb and Pfizer are two of the safest stocks investors can buy right now.
These two pharma giants are strong dividend stocks to consider buying.
These companies should benefit from vaccines, tests and beyond.
The White House reportedly plans to route extra federal funds and other assistance to the companies developing those potential SARS-CoV-2 vaccines.